the aid library

LIST OPTIONS

Filter

7137

Third progress analysis of implementation of antimicrobial resistance national action plans in the WHO South-East Asia Region

World Health Organization WHO (2022) C_WHO

Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder or impossible to treat, and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has... more

Download (221)

View PDF (257)

Recommendations for Establishing a National Maternal Near-miss Surveillance System in Latin America and the Caribbean

Pan American Health Organization (PAHO) (2022) C_WHO

Maternal mortality has fallen significantly in recent years, especially in countries that have emphasized the prevention of its main causes, such as hemorrhagic and infectious complications and hypertension , including in the Region of the Americas. In its final report on the Plan of Action to Accel... more

External Link

Global Burden of Disease (GBD) India Compare
recommended

Institute for Health Metrics and Evaluation (IHME) (2018) CC

Analyze data about India’s health levels and trends from 1990 to 2016 in this interactive tool. Use treemaps, maps, arrow diagrams, and other charts to compare causes and risks and explore patterns and trends by age and sex. Drill from a national view into specific details. Compare expected and ob... more

External Link

Antimicrobial resistance learning channel
recommended

World Health Organization WHO (2022) CC

Antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. AMR threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. It occurs when microorganisms develop resistance to me... more

Download (277)

View PDF (405)

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
recommended

World Health Organization WHO (2021) C_WHO

15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19. The specific objectives of the analysis were to: describe the clinical char... more

External Link

Effects of Heat

National Institute of Environmental Health Sciences (2022) CC

Over long periods of time, individuals and communities can adapt to their local climates. When both warmer and colder temperatures go above or below those norms rapidly, scientific evidence shows that people become vulnerable to associated health effects related to those extremes. Studies suggest th... more

Download (414)

View PDF (621)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (315)

View PDF (496)

Child labour report 2017 - The Neglected Link: effects of climate change and environmental degradation on child labour

Lisa Myers, Laura Theytaz-Bergman Terre des hommes (2017) C1

Over half a billion children are living in areas with extremely high levels of floods and nearly 160 million children live in areas of high or extremely high droughts. The World Health Organisation (WHO) estimates that 26% of the annual 6.6 million deaths of children under five are linked to environ... more

Download (279)

View PDF (457)

Regional Emergency Response Appeal for the Greater Horn of Africa

World Health Organization WHO (2022) CC

The Greater Horn of Africa is experiencing one of the worst food insecurity situations in decades. It is estimated that more than 37 million people are in Integrated Food Security Phase Classification (IPC)1 phase 3 or above and approximately 7 million children under the age of five are acutely mal... more

External Link

Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care

Saraiva R.M., Mediano M.F.F., Mendes F.S. et al World Journal of Cardiology (WJC) (2021) C2

Chagas heart disease (CHD) affects approximately 30% of patients chronically infected with the protozoa Trypanosoma cruzi. CHD is classified into four stages of increasing severity according to electrocardiographic, echocardiographic, and clinical criteria. CHD presents with a myriad of clinical man... more

Download (145)

View PDF (152)

Indoor air pollution – caused by the burning of firewood, crop waste, and dung for cooking and heating – is a major health risk for the world's poorest

Ritchie, H.; Roser, M. (2024) CC2

Indoor air pollution is caused by burning solid fuel sources – such as firewood, crop waste, and dung – for cooking and heating. Burning such fuels, particularly in poor households, results in air pollution that leads to respiratory diseases, which can result in premature death. The WHO calls... more

Download (278)

View PDF (550)

Joint statement on infant and young child feeding in emergencies - Ethiopia, July 2021

FMOH, NDRMC, UNHCR, WHO, Unicef, WFP (2021) C_WHO

The Federal Ministry of Health of Ethiopia (FMOH), the National Disaster Risk Management Commission (NDRMC) and other government actors together with UN agencies (UNICEF, UNHCR, WHO and WFP) and nutrition development partners call for all parties involved in the response to emergencies in Ethiopia t... more

External Link

Distribution of opisthorchiasis, worldwide, latest year available

World Health Organization WHO (2018) C_WHO

Map of Distribution of opisthorchiasis, worldwide, latest year available. Foodborne trematodes are a group of diseases that include the parasites Clonorchis, Opisthorchis, Fasciola and Paragonimus. These parasitic flukes have a complex life cycle involving diverse definitive hosts and one or two i... more

Download (170)

View PDF (259)

NCD risk factors - Harmful use of alcohol

World Health Organisation (WHO) World Health Organization (WHO) (2024) C_WHO

The World Health Organization's Eastern Mediterranean Regional Office (WHO EMRO) highlights the significant health and social consequences of harmful alcohol use. Excessive alcohol consumption is linked to over 200 diseases and injuries, including liver cirrhosis, pancreatitis, various cancers, hemo... more

Download (187)

View PDF (295)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

Download (421)

View PDF (584)

Time To Act Stopping Violence, Safeguarding Health Care

International Committee of the Red Cross (ICRC) (2017) C1

Doctors, nurses, ambulance drivers and first-aiders are coming under attack while trying to save lives. They are threatened, arrested or beaten, their hospitals looted or bombed. Some are unable to work because medical supplies can’t get through; some are forced to flee for their lives. Some are e... more

External Link

The Lancet Commission on pollution and health

The Lancet Commission (2017) CC

For decades, pollution and its harmful effects on people’s health, the environment, and the planet have been neglected both by Governments and the international development agenda. Yet, pollution is the largest environmental cause of disease and death in the world today, responsible for an estimat... more

External Link

An update on rabies in South Africa, 2021

National Institute for Communicable Disease NICD (2021) CC

As of 14 December 2021, a total of 19 laboratory-confirmed human rabies cases has been reported in South Africa for 2021. The cases are from Eastern Cape, KwaZuluNatal and Limpopo provinces. In addition, four probable rabies cases were reported from KwaZulu-Natal and the Eastern Cape provinces. A pr... more

Download (411)

View PDF (399)

Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

World Health Organization WHO (2021) C_WHO

COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn... more

Download (1532)

View PDF (2450)

Paediatric emergency triage, assessment and treatment: care of critically-ill children

World Health Organization WHO (2016) C_WHO

Updated Guideline. The Emergency Triage Assessment and Treatment (ETAT) guidelines provide guidance on the most common emergency conditions in children presenting at the health facility. These include but are not limited to airway obstruction and other breathing problems; circulatory impairment or ... more

Global Burden of Disease (GBD) India Compare recommended

Antimicrobial resistance learning channel recommended

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection recommended

Global Burden of Disease (GBD) India Compare
recommended

Antimicrobial resistance learning channel
recommended

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
recommended